Search
Glucose-6-phosphate Dehydrogenase Deficiency
smpdb.ca/view/SMP0000518DiseaseGlucose-6-phosphate dehydrogenase (G6PD) is an enzyme in the pentose phosphate pathway. G6PD converts glucose-6-phosphate into 6-phosphoglucono-delta-lactone. … About 400 million people (1 in 20) have G6PDD globally and it is particularly common in certain parts of Africa, Asia, the Mediterranean, and the Middle East.
Drugs: Adenosine phosphate · ATP · Magnesium cation · Iron · 5-O-phosphono-alpha-D-ribofuranosyl diphosphate · D-glyceraldehyde 3-phosphate +4 moreEnzymes: Glucose-6-phosphate isomerase, Ribose-5-phosphate isomeraseRibose-5-phosphate Isomerase Deficiency
smpdb.ca/view/SMP0000519DiseaseThere are other symptoms, including leukoencephalopathy and neuropathy, which may be caused by a toxic accumulation of ribitol and arabitol, or a potential lack of ribose-5-phosphate in RNA synthesis. … RPI is an enzyme that is involved in the pentose phosphate pathway as part of carbohydrate degradation. It reversibly converts D-ribulose 5-phosphate into D-ribose 5-phosphate.
Drugs: Adenosine phosphate · ATP · Magnesium cation · Iron · 5-O-phosphono-alpha-D-ribofuranosyl diphosphate · D-glyceraldehyde 3-phosphate +4 moreEnzymes: Glucose-6-phosphate isomerase, Ribose-5-phosphate isomeraseEstramustine phosphate Predicted Metabolism Pathway
smpdb.ca/view/SMP0174529MetabolicMetabolites of Estramustine phosphate are predicted with biotransformer.
Verapamil Calcium Channel Vasodilation Action Pathway
smpdb.ca/view/SMP0126373Drug actionThe inhibition of L-type calcium channels prevents the influx of calcium in vascular smooth muscle myocytes and the heart's cardiomyocytes, which prevents contraction of vascular smooth muscles and heart … Verapamil acts on smooth muscles and cardiac muscles. Verapamil is an L-type calcium channel blocker with antiarrhythmic, antianginal, and antihypertensive activity.
Enzymes: Voltage-dependent L-type calcium channel subunit beta-1, Voltage-dependent calcium channel subunit alpha-2/delta-1Calcium Gluceptate Drug Metabolism Pathway
smpdb.ca/view/SMP0145439MetabolicGadoversetamide passes through the liver and is then excreted from the body mainly through the kidney. … Gadoversetamide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Calcium glucoheptonateDiltiazem Calcium Channel Vasodilation Action Pathway
smpdb.ca/view/SMP0126505Drug actionActing as the main Ca2+ source for contraction in smooth and cardiac muscle, activation of L-type calcium channels allows the influx of calcium ions into the muscles upon depolarization and excitation … This effect is thought to be mediated by the voltage-dependent block of the L-type calcium channels and inhibition of calcium ion release from the ER stores, without altering the sodium-calcium coupled
Enzymes: Voltage-dependent L-type calcium channel subunit beta-1, Voltage-dependent calcium channel subunit alpha-2/delta-1Edetate calcium disodium anhydrous Drug Metabolism
smpdb.ca/view/SMP0130583MetabolicEdetate calcium disodium anhydrous passes through the liver and is then excreted from the body mainly through the kidney. … Edetate calcium disodium anhydrous is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Cinnarizine Calcium Channel Vasodilation Action Pathway
smpdb.ca/view/SMP0126667Drug actionCinnarizine is an antihistamine and a calcium channel blocker. Cinnarizine inhibits contractions of vascular smooth muscle cells by blocking L-type and T-type voltage gated calcium channels. … Cinnarizine is a drug used for the management of labyrinthine disorder symptoms, including vertigo, tinnitus, nystagmus, nausea, and vomiting.
Enzymes: Voltage-dependent T-type calcium channel subunit alpha-1G, Voltage-dependent T-type calcium channel subunit alpha-1HDiltiazem Calcium Channel Cardiac Muscle Relaxation Action Pathway
smpdb.ca/view/SMP0126292Drug actionActing as the main Ca2+ source for contraction in smooth and cardiac muscle, activation of L-type calcium channels allows the influx of calcium ions into the muscles upon depolarization and excitation … This effect is thought to be mediated by the voltage-dependent block of the L-type calcium channels and inhibition of calcium ion release from the ER stores, without altering the sodium-calcium coupled
Enzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-dependent T-type calcium channel subunit alpha-1GFlunarizine Calcium Channel Artery Dilation Action Pathway
smpdb.ca/view/SMP0126303Drug actionFlunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. … Flunarizine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel.
Enzymes: Voltage-dependent L-type calcium channel subunit beta-1, Voltage-dependent calcium channel subunit alpha-2/delta-1